Public disclosures

Chaudhuri Sarbani

Company insiders · See Remarks · ROCKET PHARMACEUTICALS, INC.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-12.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
1

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Chaudhuri Sarbani

See Remarks · ROCKET PHARMACEUTICALS, INC.

RCKT

ROCKET PHARMACEUTICALS, INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 257937 · SEC code covers open-market or private transactions · Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. · The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. · Chief Commercial & Medical Affairs Officer

2026-11-092026-11-12

≈ $11,337.14

4,872 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement